Phthalic Anhydride

Phthalic Anhydride

SCHEMBL19642997

NO.O=C1OC(=O)c2ccccc21

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.82
ALOX15 P16050 1/20 0.82
TYMS P04818 1/20 0.50
HSD17B10 Q99714 1/20 0.47
ALDH1A1 P00352 5/20 0.46
KDM4E B2RXH2 4/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
HPGD P15428 2/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
CDC25B P30305 2/20 0.45
MAPK1 P28482 3/20 0.45
TSHR P16473 2/20 0.45
APAF1 O14727 2/20 0.43
TDP2 O95551 2/20 0.43
POLB P06746 2/20 0.43
RECQL P46063 2/20 0.43
MAOA P21397 2/20 0.43
CES2 O00748 1/20 0.43
TERT O14746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phthalic Anhydride SCHEMBL380499 0.91 TDP1 (1.00) TDP1ALOX15TYMSHSD17B10ALDH1A1
Phthalic Anhydride SCHEMBL220 0.91 TDP1 (1.00) TDP1ALOX15TYMSHSD17B10ALDH1A1
Phthalic Anhydride SCHEMBL29356227 0.91 TDP1 (1.00) TDP1ALOX15TYMSHSD17B10ALDH1A1
Phthalic Anhydride SCHEMBL2206535 0.89 TDP1 (0.74) TDP1ALOX15TYMSHSD17B10ALDH1A1
Phthalic Anhydride SCHEMBL29189778 0.88 TDP1 (0.82) TDP1ALOX15TYMSHSD17B10ALDH1A1
Phthalic Anhydride SCHEMBL18038400 0.88 TDP1 (0.93) TDP1ALOX15TYMSHSD17B10ALDH1A1
Phthalic Anhydride SCHEMBL1871448 0.88 TDP1 (0.93) TDP1ALOX15TYMSHSD17B10ALDH1A1
Phthalic Anhydride SCHEMBL17275164 0.88 TDP1 (0.93) TDP1ALOX15TYMSHSD17B10ALDH1A1
Phthalic Anhydride SCHEMBL21824259 0.88 TDP1 (0.93) TDP1ALOX15TYMSHSD17B10ALDH1A1
Phthalic Anhydride SCHEMBL21874610 0.88 TDP1 (0.93) TDP1ALOX15TYMSHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11161812-B2 Production of cyclic imides suitable for oxidation catalysis EXXONMOBIL CHEMICAL PATENTS INC. (US) 2021-11-02 US disclosed
US-11014883-B2 Production of cyclic imides suitable for oxidation catalysis EXXONMOBIL CHEMICAL PATENTS INC. (US) 2021-05-25 US disclosed
US-20190152911-A1 Production of Cyclic Imides Suitable for Oxidation Catalysis EXXONMOBIL CHEMICAL PATENTS INC. 2019-05-23 US disclosed
US-20190135749-A1 Production of Cyclic Imides Suitable for Oxidation Catalysis EXXONMOBIL CHEMICAL PATENTS INC. 2019-05-09 US disclosed
WO-2017204936-A1 PRODUCTION OF CYCLIC IMIDES SUITABLE FOR OXIDATION CATALYSIS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2017-11-30 WO disclosed
WO-2017204935-A1 PRODUCTION OF CYCLIC IMIDES SUITABLE FOR OXIDATION CATALYSIS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2017-11-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11161812-B2 Production of cyclic imides suitable for oxidation catalysis HPD, HAO2, HPGD TDP1 1389/4885ALOX15 932/4885TYMS 2373/4885
US-20190152911-A1 Production of Cyclic Imides Suitable for Oxidation Catalysis HPD, HAO2, HPGD TDP1 1389/4885ALOX15 932/4885TYMS 2373/4885
US-11014883-B2 Production of cyclic imides suitable for oxidation catalysis HPD, HAO2, HPGD TDP1 1389/4885ALOX15 932/4885TYMS 2373/4885
US-20190135749-A1 Production of Cyclic Imides Suitable for Oxidation Catalysis HPD, HAO2, HPGD TDP1 1389/4885ALOX15 932/4885TYMS 2373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.